Versant Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-188
| Closed | -$2.33K | – | 2818 |
|
|
2025
Q4 | $2.33K | Sell |
188
-75
| -29% | -$997 | ﹤0.01% | 2426 |
|
|
2025
Q3 | $3.77K | Buy |
+263
| New | +$3.6K | ﹤0.01% | 2305 |
|
|
2025
Q2 | – | Sell |
-1,133
| Closed | -$24.9K | – | 2676 |
|
|
2025
Q1 | $24.9K | Hold |
1,133
| – | – | ﹤0.01% | 1221 |
|
|
2024
Q4 | $25.7K | Buy |
1,133
+34
| +3% | +$742 | 0.01% | 900 |
|
|
2024
Q3 | $20K | Buy |
1,099
+282
| +35% | +$6.54K | ﹤0.01% | 802 |
|
|
2024
Q2 | $23.8K | Buy |
+817
| New | +$24.2K | 0.01% | 645 |
|
|
2024
Q1 | – | Sell |
-86
| Closed | -$3.75K | – | 1912 |
|
|
2023
Q4 | $3.75K | Sell |
86
-1
| -1% | -$39 | ﹤0.01% | 1075 |
|
|
2023
Q3 | $3.32K | Buy |
87
+20
| +30% | +$841 | ﹤0.01% | 1124 |
|
|
2023
Q2 | $2.76K | Buy |
+67
| New | +$3.23K | ﹤0.01% | 1256 |
|
|
2020
Q2 | – | Sell |
-24
| Closed | -$1K | – | 1407 |
|
|
2020
Q1 | $1K | Sell |
24
-4
| -14% | -$210 | ﹤0.01% | 1152 |
|
|
2019
Q4 | $1K | Hold |
28
| – | – | ﹤0.01% | 1235 |
|
|
2019
Q3 | $1K | Sell |
28
-19
| -40% | -$1.13K | ﹤0.01% | 1252 |
|
|
2019
Q2 | $2K | Sell |
47
-77
| -62% | -$3.96K | ﹤0.01% | 1180 |
|
|
2019
Q1 | $6K | Sell |
124
-82
| -40% | -$4.18K | ﹤0.01% | 1052 |
|
|
2018
Q4 | $9K | Sell |
206
-6
| -3% | -$329 | ﹤0.01% | 856 |
|
|
2018
Q3 | $13K | Sell |
212
-10
| -5% | -$621 | 0.01% | 809 |
|
|
2018
Q2 | $14K | Sell |
222
-47
| -17% | -$2.91K | 0.01% | 769 |
|
|
2018
Q1 | $14K | Hold |
269
| – | – | 0.01% | 767 |
|
|
2017
Q4 | $12K | Sell |
269
-9
| -3% | -$441 | ﹤0.01% | 847 |
|
|
2017
Q3 | $14K | Buy |
278
+41
| +17% | +$2.11K | 0.01% | 717 |
|
|
2017
Q2 | $12K | Buy |
237
+83
| +54% | +$3.96K | 0.01% | 794 |
|
|
2017
Q1 | $6K | Buy |
154
+6
| +4% | +$256 | ﹤0.01% | 992 |
|
|
2016
Q4 | $6K | Sell |
148
-24
| -14% | -$976 | ﹤0.01% | 977 |
|
|
2016
Q3 | $7K | Hold |
172
| – | – | ﹤0.01% | 911 |
|
|
2016
Q2 | $6K | Sell |
172
-8
| -4% | -$288 | ﹤0.01% | 922 |
|
|
2016
Q1 | $6K | Sell |
180
-344
| -66% | -$10.7K | ﹤0.01% | 910 |
|
|
2015
Q4 | $17K | Buy |
+524
| New | +$16.4K | 0.01% | 555 |
|
Other funds holding IART
RCMNY
PCMI
Versant Capital Management's IART Position: Q1 2026 in Review
Versant Capital Management sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 188 shares — an estimated $2.33K sold.
Versant Capital Management first reported a position in IART in Q4 2015 and held it in 27 quarters. The position peaked at $25.7K in Q4 2024. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Versant Capital Management reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
- Versant Capital Management sold 188 Integra LifeSciences shares in Q1 2026, an estimated $2.33K.
- Versant Capital Management first reported a position in Integra LifeSciences in Q4 2015 and held it in 27 quarters.
- Versant Capital Management's Integra LifeSciences position peaked at $25.7K in Q4 2024.
- 202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.